Snowball logo
logo
GLSH

Gelesis Holdings Inc.

GLSHQ • PINK
$0.0001$0.00  (0%)
Estimate
EPS
-7.1
Beta
3,282.913
About the company
Ticker
GLSHQ
ISIN
Country
United States of America
Sector (GICS)
Healthcare
Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Further, it develops pre-clinical product GS300 for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Gelesis Holdings, Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts. On October 30, 2023, Gelesis Holdings, Inc., along its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Frequently asked questions

What sector does Gelesis Holdings Inc. (GLSHQ) operate in?

Gelesis Holdings Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Gelesis Holdings Inc. (GLSHQ) current stock price?

As of the latest data, Gelesis Holdings Inc. stock price is $0.00, with a previous close of $0.00.

What is Gelesis Holdings Inc. (GLSHQ) current market capitalization?

Gelesis Holdings Inc. market cap is approximately 7.33 thousand.

What is Gelesis Holdings Inc. (GLSHQ) Earnings Per Share (EPS)?

The trailing EPS is -$7.10.

Does Gelesis Holdings Inc. (GLSHQ) pay dividends?

No. Gelesis Holdings Inc. does not pay a dividend.

What is Gelesis Holdings Inc. (GLSHQ) beta (volatility) score?

Gelesis Holdings Inc. has a beta of 3282.913, indicating very high volatility compared to the market.